Unlocking the Potential of Antibody-Drug Conjugates in Cancer Medicine: Efficacy and Side Effects
Saved in:
| Main Author: | Marcus Vetter |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
THE HEALTHBOOK COMPANY LTD.
2023-10-01
|
| Series: | healthbook TIMES. Oncology Hematology |
| Online Access: | https://doi.org/10.36000/hbT.OH.2023.17.115 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Antibody-Drug Conjugates in Cancer
by: Marcus Vetter
Published: (2024-06-01) -
Unlocking the potential of antibody-drug conjugates in cervical cancer: emerging targets and clinical trials
by: Yue Zhang, et al.
Published: (2025-07-01) -
Unlocking the therapeutic potential of antibody–drug conjugates in targeting molecular biomarkers in non-small cell lung cancer
by: Shruti Soni, et al.
Published: (2025-03-01) -
Fourth Swiss Annual Meeting on HER2-Positive Breast Cancer: Antibody-Drug Conjugates in HER2-Positive Disease and Beyond
by: Marcus Vetter, et al.
Published: (2025-06-01) -
The Impact of Conjugation Mode and Site on Tubulysin Antibody‐Drug‐Conjugate Efficacy and Stability
by: Sayumi Yamazoe, et al.
Published: (2025-08-01)